MarginsXMarginsX
Home › Markets › Health Care › SXTP

60 Degrees Pharmaceuticals Inc. (SXTP)

SXTP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.4938
-4.65% on the day
Market cap
$1.7M
Nano cap
Revenue · 2025
$1.0M
+65.5% on 2024
Net income · 2025
-$7.4M
-732.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/0001554855-26-000467-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSXTP on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2023
SEC CIK0001946563
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.0M
Net income-$7.4M
Operating income-$7.8M
Net margin-732.5%
Operating margin-771.6%
Revenue growth+65.5%
Cash$1.5M
Total assets$5.4M
P/E (computed)Net income was not positive
P/S (computed)1.7×

Warning signs

Cash runway
1.4 months
$1.0M cash at June 30, 2026
Share count, 1 year
+242.7%
2025-08-13 to 2026-08-14 · +14454.2% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$30K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date these consolidated condensed financial statements are issued. 6 Management plans to fund operations of the Company through third party and related party debt/advances, private placement of restricted securities and the issuance of stock in a subsequent offering until such "
10-Q 2026-08-14
Cash and burn$1.0M cash; operating cash flow -$2.2M a quarter.Report 2026-06-30
Shares outstanding3,516,988 (2026-08-14); 4,104,469 a year earlier; 5,799,535 three years earlier. 1y figure adjusted for splits (1-for-4 overall); 3y figure adjusted for splits (1-for-240 overall).Cover page 2026-08-14
Reverse splits, 3 years3; latest 1-for-4 on 2026-01-20Source 2026-01-20
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the marketLatest 2026-03-13
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-01-23
AuditorRBSM LLP, LAS VEGAS, Nevada, United StatesPCAOB Form AP 2026-03-31
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $30K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$208K-$2.3M-$2.2M$1.0M$150K$1.1M10-Q 2026-08-14
Q1 2026
2026-03-31
$162K-$2.1M-$2.7M$3.3M$150K$1.0M10-Q 2026-05-15
Q4 2025
2025-12-31
$303K-$1.4M-$1.7M$1.5M$150K$1.0M10-K 2026-03-30
Q3 2025
2025-09-30
$438K-$2.3M-$2.1M$4.1M$150K$944K10-Q 2025-11-13
Q2 2025
2025-06-30
$101K-$1.7M-$1.5M$2.0M$150K$641K10-Q 2026-08-14
Q1 2025
2025-03-31
$164K-$1.9M-$1.6M$3.5M$150K$665K10-Q 2026-05-15
Q4 2024
2024-12-31
$242K-$2.0M-$1.6M$1.7M$150K$608K10-K 2026-03-30
Q3 2024
2024-09-30
$135K-$2.2M-$1.7M$3.3M$150K$492K10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
S-32026-08-14
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-11-16
Latest current report
CURRENT REPORT
8-K2026-11-06
Latest proxy
DEFINITIVE PROXY STATEMENT
DEF 14A2026-07-02

Source: SEC EDGAR submissions feed, 227 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-12.9%
1 month-42.4%
3 months-56.1%
Year to date-74.5%
1 year-88.9%
From 52-week high-90.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
SXTPW60 Degrees Pharmaceuticals Inc. Warrant$0.0260

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ENLVEnlivex Ltd.$1.12-5.88%$1.7M
HCWBHCW Biologics Inc.$0.8000+3.48%$1.8M
XRTXXORTX Therapeutics Inc. Common Shares$1.04-5.45%$1.9M
ARTLArtelo Biosciences Inc.$1.70-17.87%$1.6M
ONCOOnconetix Inc.$2.91-9.35%$1.9M
PPCBPropanc Biopharma Inc.$1.89-2.62%$2.0M
APVOAptevo Therapeutics Inc.$0.5486-7.66%$1.5M
CMNDClearmind Medicine Inc. Common Shares$4.18-7.67%$2.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier